期刊
PEPTIDES
卷 31, 期 7, 页码 1368-1373出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.peptides.2010.04.011
关键词
Schizophrenia; Stable tubule-only polypeptide (STOP); Activity-dependent neuroprotective protein; NAP (davunetide); Hyperactivity; Visual memory
资金
- Eshkol fellowship
- Allon Therapeutics Inc.
- A.M.N. Foundation
NAP (generic name, davunetide) is an active fragment of activity-dependent neuroprotective protein (ADNP). ADNP -/- embryos exhibit CNS dysgenesis and die in utero. ADNP+/ mice survive but demonstrate cognitive dysfunction coupled with microtubule pathology. NAP treatment ameliorates, in part, ADNP-associated dysfunctions. The microtubule, stable tubule-only polypeptide (STOP) knockout mice were shown to provide a reliable model for schizophrenia. Here, STOP -/- as well as STOP+/ showed schizophrenia-like symptoms (hyperactivity) that were ameliorated by chronic treatment with the antipsychotic drug, clozapine. Daily intranasal NAP treatment significantly decreased hyperactivity in the STOP+/- mice and protected visual memory. (C) 2010 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据